The Ets dominant repressor En/Erm enhances intestinal epithelial tumorigenesis in ApcMin mice

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Jedlicka, Paul ^a   Sui, Xiaomei ^a   Gutierrez Hartmann, Arthur ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; ENGRAILED REPRESSOR PROTEIN; PROTEIN ERM; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR ETS; UNCLASSIFIED DRUG; UVOMORULIN; VILLIN; DNA BINDING PROTEIN; ETV5 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE CARCINOMA; INTESTINE CRYPT; INTESTINE EPITHELIUM; INTESTINE VILLUS; MOUSE; NONHUMAN; PHENOTYPE; REPRESSOR GENE; TRANSCRIPTION INITIATION; TRANSGENE; TUMOR VOLUME; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CARCINOMA; DOMINANT GENE; GENE EXPRESSION REGULATION; GENETICS; INTESTINE TUMOR; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; CARCINOMA; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, DOMINANT; IMMUNOHISTOCHEMISTRY; INTESTINAL NEOPLASMS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MODELS, GENETIC; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-ETS; TRANSCRIPTION FACTORS; TRANSGENES;

EID: 68249149222     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-197     Document Type: Article

References (19)

1. Oikawa T Yamada T Molecular biology of the Ets family of transcription factors Gene 2003, 303:11-34 10.1016/S0378-1119(02)01156-3 12559563
2. Sharrocks AD The ETS-domain transcription factor family Nat Rev Mol Cell Biol 2001, 2(11):827-837 10.1038/35099076 11715049
3. Feldman RJ Sementchenko VI Watson DK The epithelial-specific Ets factors occupy a unique position in defining epithelial proliferation, differentiation and carcinogenesis Anticancer Res 2003, 23(3A):2125-2131 12894586
4. Hsu T Trojanowska M Watson DK Ets proteins in biological control and cancer J Cell Biochem 2004, 91(5):896-903 2265084 15034925 10.1002/ jcb.20012
5. Seth A Watson DK ETS transcription factors and their emerging roles in human cancer Eur J Cancer 2005, 41(16):2462-2478 10.1016/ j.ejca.2005.09.005 16213704
6. Man AK Young LJ Tynan JA Lesperance J Egeblad M Werb Z Hauser CA Muller WJ Cardiff RD Oshima RG Ets2-dependent stromal regulation of mouse mammary tumors Mol Cell Biol 2003, 23(23):8614-8625 262691 14612405 10.1128/MCB.23.23.8614-8625.2003
7. Shepherd TG Kockeritz L Szrajber MR Muller WJ Hassell JA The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis Curr Biol 2001, 11(22):1739-1748 10.1016/ S0960-9822(01)00536-X 11719215
8. Tynan JA Wen F Muller WJ Oshima RG Ets2-dependent microenvironmental support of mouse mammary tumors Oncogene 2005, 24(46):6870-6876 10.1038/ sj.onc.1208856 16007139
9. Jedlicka P Gutierrez-Hartmann A Ets transcription factors in intestinal morphogenesis, homeostasis and disease Histol Histopathol 2008, 23(11):1417-1424 18785124
10. Jedlicka P Sui X Sussel L Gutierrez-Hartmann A Ets transcription factors control epithelial maturation and transit and crypt-villus morphogenesis in the mammalian intestine Am J Pathol 2009, 174(4):128-1290 10.2353/ ajpath.2009.080409 19264912
11. Hollenhorst PC Jones DA Graves BJ Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors Nucleic Acids Res 2004, 32(18):5693-5702 524310 15498926 10.1093/nar/gkh906
12. Su LK Kinzler KW Vogelstein B Preisinger AC Moser AR Luongo C Gould KA Dove WF Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene Science 1992, 256(5057):668-670 10.1126/ science.1350108 1350108
13. Heyer J Yang K Lipkin M Edelmann W Kucherlapati R Mouse models for colorectal cancer Oncogene 1999, 18(38):5325-5333 10.1038/sj.onc.1203036 10498885
14. Boivin GP Washington K Yang K Ward JM Pretlow TP Russell R Besselsen DG Godfrey VL Doetschman T Dove WF et al Pathology of mouse models of intestinal cancer: Consensus report and recommendations Gastroenterology 2003, 124(3):762-777 10.1053/gast.2003.50094 12612914
15. Lawrance AK Deng L Brody LC Finnell RH Shane B Rozen R Genetic and nutritional deficiencies in folate metabolism influence tumorigenicity in Apcmin/+ mice J Nutr Biochem 2007, 18(5):305-312 10.1016/ j.jnutbio.2006.06.001 16963246
16. Dietrich WF Lander ES Smith JS Moser AR Gould KA Luongo C Borenstein N Dove W Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse Cell 1993, 75(4):631-639 10.1016/0092-8674(93)90484-8 8242739
17. Gould KA Luongo C Moser AR McNeley MK Borenstein N Shedlovsky A Dove WF Hong K Dietrich WF Lander ES Genetic evaluation of candidate genes for the Mom1 modifier of intestinal neoplasia in mice Genetics 1996, 144(4):1777-1785 1207727 8978063
18. Madison BB Dunbar L Qiao XT Braunstein K Braunstein E Gumucio DL Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine J Biol Chem 2002, 277(36):33275-33283 10.1074/jbc.M204935200 12065599
19. Sussan TE Yang A Li F Ostrowski MC Reeves RH Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome Nature 2008, 451(7174):73-75 10.1038/nature06446 18172498